PH16723A - Injectable composition of rapamycin - Google Patents

Injectable composition of rapamycin

Info

Publication number
PH16723A
PH16723A PH25691A PH25691A PH16723A PH 16723 A PH16723 A PH 16723A PH 25691 A PH25691 A PH 25691A PH 25691 A PH25691 A PH 25691A PH 16723 A PH16723 A PH 16723A
Authority
PH
Philippines
Prior art keywords
rapamycin
polyoxyethylated
injectable composition
composition
compositions
Prior art date
Application number
PH25691A
Other languages
English (en)
Inventor
Nath Sehgal Surendra
Harold Arthur Baker
Anne Marie Sidorowicz
Claude Vezina
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Publication of PH16723A publication Critical patent/PH16723A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH25691A 1980-06-02 1981-06-01 Injectable composition of rapamycin PH16723A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15525080A 1980-06-02 1980-06-02

Publications (1)

Publication Number Publication Date
PH16723A true PH16723A (en) 1984-01-25

Family

ID=22554656

Family Applications (1)

Application Number Title Priority Date Filing Date
PH25691A PH16723A (en) 1980-06-02 1981-06-01 Injectable composition of rapamycin

Country Status (9)

Country Link
EP (1) EP0041795B1 (de)
JP (1) JPS5714523A (de)
AT (1) ATE11218T1 (de)
AU (1) AU543727B2 (de)
CA (1) CA1177399A (de)
DE (1) DE3168276D1 (de)
ES (1) ES8207426A1 (de)
IE (1) IE51295B1 (de)
PH (1) PH16723A (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429436A3 (en) * 1985-12-06 1991-12-27 The University Of Kansas Prodrugs of rapamycin
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
IT1191802B (it) * 1986-05-30 1988-03-23 So Ri Fa Srl Grasso autoemulsionante per uso farmaceutico e cosmetico,sua preparazione ed uso
JPH0570366A (ja) * 1991-03-08 1993-03-23 Meiji Seika Kaisha Ltd 薬用組成物
US5322772A (en) * 1991-04-09 1994-06-21 Children's Research Institute Rapamycin assay
JPH07505628A (ja) * 1992-03-30 1995-06-22 アメリカン・ホーム・プロダクツ・コーポレイション 静脈注射用のラパマイシン製剤
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5536729A (en) * 1993-09-30 1996-07-16 American Home Products Corporation Rapamycin formulations for oral administration
AU688782B2 (en) * 1993-09-30 1998-03-19 Wyeth Rapamycin formulations for oral administration
IL111004A (en) * 1993-09-30 1998-06-15 American Home Prod Oral formulations of rapamycin
US5516770A (en) * 1993-09-30 1996-05-14 American Home Products Corporation Rapamycin formulation for IV injection
US5616588A (en) 1993-09-30 1997-04-01 American Home Products Corporation Rapamycin formulation for IV injection
JP3833248B2 (ja) 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法
BE1009856A5 (fr) 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
GB9826882D0 (en) * 1998-12-07 1999-01-27 Novartis Ag Organic compounds
PT1553940E (pt) 2002-07-30 2008-05-09 Wyeth Corp Formulações parentéricas contendo um hidroxi-éster de rapamicina
WO2004027027A2 (en) 2002-09-18 2004-04-01 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
AU2004274026A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US7846940B2 (en) 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
CA2597590A1 (en) 2005-02-09 2006-08-17 Macusight, Inc. Formulations for ocular treatment
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
CN1919194A (zh) * 2006-08-17 2007-02-28 刘瑜玲 西罗莫司的液体组合物
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
CN107753473A (zh) * 2016-08-18 2018-03-06 杭州高田生物医药有限公司 一种全反式维甲酸注射剂与应用
CN114366715A (zh) * 2022-01-28 2022-04-19 严鹏科 雷帕霉素自微乳注射剂及其制备方法及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518819B1 (de) * 1965-04-03 1969-12-04 Basf Ag Loesungsvermittler fuer pharmazeutische Zwecke
ZA737247B (en) 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US3993749A (en) 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
DE2528257C2 (de) 1974-07-04 1986-02-13 Sandoz-Patent-GmbH, 7850 Lörrach Neue galenische Zubereitung
BE877700A (fr) 1978-11-03 1980-01-14 Ayerst Mckenna & Harrison Compositions pharmaceutiques a base de rapamycine pour le traitement de tumeurs carcinogenes

Also Published As

Publication number Publication date
IE51295B1 (en) 1986-11-26
CA1177399A (en) 1984-11-06
ES502647A0 (es) 1982-10-01
AU7093181A (en) 1981-12-10
AU543727B2 (en) 1985-05-02
ATE11218T1 (de) 1985-02-15
EP0041795B1 (de) 1985-01-16
JPS5714523A (en) 1982-01-25
EP0041795A3 (en) 1982-09-08
IE811215L (en) 1981-12-02
DE3168276D1 (en) 1985-02-28
EP0041795A2 (de) 1981-12-16
ES8207426A1 (es) 1982-10-01

Similar Documents

Publication Publication Date Title
DE3168276D1 (en) Injectable composition of rapamycin
DE3767615D1 (de) Pharmazeutikum sowie verfahren zu seiner herstellung.
ATE160378T1 (de) Verfahren zur herstellung von glykosid-estern und zusammensetzungen daraus
EP0321777A3 (en) Process for the transesterification of fat and oil
ATE136549T1 (de) Verfahren zur herstellung von aus di- oder tri- carboxylsäuren abgeleiteten grenzflächenaktiven mitteln
HUT46851A (en) Process for producing improves pharmaceutical compositions containing flunarazine
AT373884B (de) Verfahren zur herstellung neuer 4-substituierter thiazoloxamsaeuren sowie ihrer salze und ester
DE3874260D1 (de) Verfahren zur herstellung von estern ungesaettigter alkohole.
DE69004561D1 (de) Zubereitung zur perkutanen anwendung.
GB2001977B (en) Process for the manufacture of partially neutralised mixed esters from lactic acid citric acid and partial fatty acid esters of glycerol
GB2001072A (en) Process for the manufacture of mixed esters from hydroxy. acids and partial fatty acid glycerides
JPS53137244A (en) Non-toxic stabilized composition of olefinic high polymer
JPS5764609A (en) Cyclophosphamide composition for rectal administration
JPS56131344A (en) Preparation of foaming fat or oil for cake
JPS5675437A (en) Suppository base
JPS53112945A (en) Antistatic agnet
JPS537627A (en) Optically active unsaturated esters and their preparation
JPS545948A (en) Cyclopropanecarboxylic acid esters, process for their prparation, and isecticide having low toxicity to fishees, containing the same as active constituents
ES8601692A1 (es) Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
JPS5380405A (en) Surface active agent for emulsion fuel
JPS5266563A (en) Polyoxymethylene compositions
HU9300287D0 (en) Method for racemizing non-racemic carboxylic acids of 3-oxo-cyclopenthane or 3-oxo-cyclohexane as well as their esters produced with alcohols of 1 to 6 carbon atoms
PH15767A (en) (+)-(3-methyl-4-oxo-5n-piperidinothiazolidin-2-ylidene)acetic acid esters,composition and method of preparation
EP0090273A3 (de) Fettsaüre-Ester von Alkoxylatderivaten von Phenol und ihre Verwendung als Faserveredelungsmittel
JPS5325561A (en) Optical active lactam-2-acetic acid esters and their preparation